Related Experiment Videos
Doxapram and the neuromuscular junction.
B J Pollard1, N P Randall, B J Pleuvry
1Department of Anaesthesia and Physiological Sciences, University of Manchester.
British Journal of Anaesthesia
|June 1, 1989
Summary
Doxapram enhances neuromuscular transmission at higher doses, acting presynaptically. However, it can inhibit transmission post-junctionally under partial neuromuscular block, suggesting complex dose-dependent effects.
Area of Science:
- Pharmacology
- Neuroscience
Background:
- Neuromuscular transmission is crucial for muscle function.
- Doxapram is a respiratory stimulant with potential effects on neuromuscular function.
Purpose of the Study:
- To investigate the effects of doxapram on neuromuscular transmission.
- To elucidate the mechanism of doxapram's action at the neuromuscular junction.
Main Methods:
- Utilized the rat phrenic nerve-diaphragm preparation.
- Administered doxapram in varying concentrations.
- Examined acetylcholinesterase activity.
- Assessed doxapram's effects during partial neuromuscular blockade induced by various agents.
Main Results:
- Doxapram augmented neuromuscular transmission dose-dependently above a threshold concentration (5 x 10(-5) mol litre-1).
- No acetylcholinesterase inhibition was observed within the facilitatory concentration range.
- Doxapram induced dose-related depression of neuromuscular transmission during partial blockade, particularly with presynaptically active blocking agents.
- Facilitatory effects were diminished or abolished with presynaptic blockade but apparent with postsynaptic blockade.
Conclusions:
- Doxapram exhibits a presynaptic facilitatory action at the neuromuscular junction.
- An inhibitory, potentially post-junctional, action of doxapram is revealed under partial neuromuscular block.
- Observed effects occur at concentrations higher than typically achieved clinically.